Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fampyra vs Acemit vs Placebo in Episodic Ataxia Type 2
DRKS00005258Phase 3Completed
- Sponsor
- LMU Klinikum
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in episodic ataxia type 2 (EA2) and Genetic Ataxias comparing Fampyra sequence, Acemit sequence and Placebo sequence (3 arms). Started Aug 2013; status: completed.
02
Drugs
dalfampridineacetazolamide
03
Conditions
episodic ataxia type 2 (EA2)Genetic Ataxias
Beyond the preview
Go deeper on DRKS00005258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00005258.